MRTX Stock Takes A Hit After Receiving A Lowball Takeover Bid
Bristol Myers Squibb (BMY) offered to buy Mirati Therapeutics (MRTX) for up to $5.8 billion, but MRTX stock tumbled Monday ...
Bristol Myers Squibb (BMY) offered to buy Mirati Therapeutics (MRTX) for up to $5.8 billion, but MRTX stock tumbled Monday ...
The “Rookie to Real Estate Investor in 90 Days” series is back, and we’re checking in with three mentees as ...
Copyright © 2022 - Index Investing News.
Index Investing News is not responsible for the content of external sites.